Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Blinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults.Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasmActive, not recruitingPhase 22024-09-19NCT03541083

1 results · Page 1 of 1

Swipe the table sideways for more columns.

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
BE-Antwerpen Edegem-UZAAntwerpBelgium2
BE-Antwerpen-ZNASTUIVENBERGAntwerpBelgium8
BE-Brugge-AZBRUGGEBrugesBelgium6
BE-Gent-UZGENTGhentBelgium7
BE-Leuven-UZLEUVENLeuvenBelgium10
BE-Roeselare-AZDELTARoeselareBelgium7
NL-Amersfoort-MEANDERMCAmersfoortNetherlands13
NL-Amsterdam-AMCAmsterdamNetherlands10
NL-Amsterdam-VUMCAmsterdamNetherlands10
NL-Den Haag-HAGAThe HagueNetherlands13
NL-Enschede-MSTEnschedeNetherlands11
NL-Groningen-UMCGGroningenNetherlands17
NL-Leiden-LUMCLeidenNetherlands9
NL-Maastricht-MUMCMaastrichtNetherlands13
NL-Nieuwegein-ANTONIUSNieuwegeinNetherlands10
NL-Rotterdam-ERASMUSMCRotterdamNetherlands14
NL-Utrecht-UMCUTRECHTUtrechtNetherlands16
NL-Zwolle-ISALAZwolleNetherlands13